Melinta Therapeutics
44 Whippany Rd, Suite 280
Morristown
New Jersey
07960
United States
Tel: n/a
Fax: n/a
Website: http://www.melinta.com/
Email: info@melinta.com
160 articles about Melinta Therapeutics
-
Rib-X Pharmaceuticals, Inc. Appoints Tom Kassberg Chief Business Officer
9/4/2009
-
Rib-X Pharmaceuticals, Inc. Antibiotic Drug Discovery Platform Discovers Novel Compounds with Activity Against Key Multiple Drug Resistant Gram-negative Bacteria
8/31/2009
-
Rib-X Pharmaceuticals, Inc. Antibiotic Passes Clinical Trial, Hopes to Snag Partner
8/5/2009
-
Rib-X Pharmaceuticals, Inc. Appoints Dr. Russell Greig to Board of Directors
6/30/2009
-
Rib-X Pharmaceuticals, Inc. Granted Key Antibiotic Patent in China
4/15/2009
-
Rib-X Pharmaceuticals, Inc. Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009
4/2/2009
-
Rib-X Pharmaceuticals, Inc. Raises $25 Million
2/5/2009
-
Rib-X Pharmaceuticals, Inc. Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing
1/26/2009
-
Rib-X Pharmaceuticals, Inc. Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin
12/8/2008
-
Rib-X Pharmaceuticals, Inc. Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
10/27/2008
-
Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board
9/9/2008
-
Rib-X Pharmaceuticals, Inc. Appoints Dr. Joseph Amprey to Board of Directors
9/3/2008
-
Rib-X Pharmaceuticals, Inc. Appoints Dr. George Milne as Executive Chairman of the Board of Directors
7/31/2008
-
Rib-X Pharmaceuticals, Inc. Appoints Nancy Motola as Senior Vice President of Regulatory Affairs
5/6/2008
-
Rib-X Pharmaceuticals, Inc. Renews Collaborative Agreement with the Medical Research Council
4/14/2008
-
Rib-X Pharmaceuticals, Inc. Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741
1/4/2008
-
Rib-X Pharmaceuticals, Inc. and the Medical Research Council Announce Key Collaboration
4/25/2007
-
Rib-X Pharmaceuticals, Inc. Raises $50 Million In Series C Financing
6/20/2006
-
Rib-X Pharmaceuticals, Inc. And Wakunaga Pharmaceutical Company Announce License Agreement For Quinolone Antibiotic
6/1/2006
-
Rib-X Pharmaceuticals, Inc., Novel Antibiotic Discovery Firm, Launches First Clinical Trial From Ribosome-Based Technology Platform
12/19/2005